Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Montgomery

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
International Clinical Psychopharmacology|August 1, 2006
Escitalopram versus venlafaxine XR in the treatment of depressionStuart A Montgomery, Henning F Andersen
International Clinical Psychopharmacology|January 16, 2014
A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?Connie Sanchez, Elin H Reines, Stuart A Montgomery
International Clinical Psychopharmacology|February 25, 2003
Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's diseaseStuart A Montgomery, L J Thal, R Amrein
International Clinical Psychopharmacology|May 27, 2014
Lack of efficacy of moclobemide or imipramine in the treatment of recurrent brief depression: results from an exploratory randomized, double-blind, placebo-controlled treatment studyDavid S Baldwin, Mary Green, Stuart A Montgomery
Journal of Clinical Psychopharmacology|November 28, 2002
Effectiveness of venlafaxine, extended release formulation, in the short-term and long-term treatment of generalized anxiety disorder: results of a survival analysisStuart A Montgomery, Vincent Mahé, Vincent Haudiquet, et al.
The International Journal of Neuropsychopharmacology|December 20, 2005
Discontinuation symptoms in depression and anxiety disordersDavid S Baldwin, Stuart A Montgomery, Rico Nil, et al.
International Clinical Psychopharmacology|January 8, 2014
Efficacy of once-daily extended release quetiapine fumarate in patients with different levels of severity of generalized anxiety disorderStuart A Montgomery, Julie C Locklear, Henrik Svedsäter, et al.
International Clinical Psychopharmacology|June 23, 2009
The efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomniaStuart A Montgomery, Barry K Herman, Edward Schweizer, et al.
CNS Spectrums|June 6, 2014
Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trialsStuart A Montgomery, Carl P Gommoll, Changzheng Chen, et al.
International Clinical Psychopharmacology|September 2, 2016
Early improvement with pregabalin predicts endpoint response in patients with generalized anxiety disorder: an integrated and predictive data analysisStuart A Montgomery, Gavin Lyndon, Mary Almas, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
International Clinical Psychopharmacology|August 1, 2006
Escitalopram versus venlafaxine XR in the treatment of depressionStuart A Montgomery, Henning F Andersen
International Clinical Psychopharmacology|January 16, 2014
A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?Connie Sanchez, Elin H Reines, Stuart A Montgomery
International Clinical Psychopharmacology|February 25, 2003
Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's diseaseStuart A Montgomery, L J Thal, R Amrein
International Clinical Psychopharmacology|May 27, 2014
Lack of efficacy of moclobemide or imipramine in the treatment of recurrent brief depression: results from an exploratory randomized, double-blind, placebo-controlled treatment studyDavid S Baldwin, Mary Green, Stuart A Montgomery
Journal of Clinical Psychopharmacology|November 28, 2002
Effectiveness of venlafaxine, extended release formulation, in the short-term and long-term treatment of generalized anxiety disorder: results of a survival analysisStuart A Montgomery, Vincent Mahé, Vincent Haudiquet, et al.
The International Journal of Neuropsychopharmacology|December 20, 2005
Discontinuation symptoms in depression and anxiety disordersDavid S Baldwin, Stuart A Montgomery, Rico Nil, et al.
International Clinical Psychopharmacology|January 8, 2014
Efficacy of once-daily extended release quetiapine fumarate in patients with different levels of severity of generalized anxiety disorderStuart A Montgomery, Julie C Locklear, Henrik Svedsäter, et al.
International Clinical Psychopharmacology|June 23, 2009
The efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomniaStuart A Montgomery, Barry K Herman, Edward Schweizer, et al.
CNS Spectrums|June 6, 2014
Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trialsStuart A Montgomery, Carl P Gommoll, Changzheng Chen, et al.
International Clinical Psychopharmacology|September 2, 2016
Early improvement with pregabalin predicts endpoint response in patients with generalized anxiety disorder: an integrated and predictive data analysisStuart A Montgomery, Gavin Lyndon, Mary Almas, et al.
Pageof 5